Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platinum Sensitive Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03562533
What this trial is testing

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Carcinoma
Konkuk University Medical Center 432
Not applicableStudy completedNCT02163720
What this trial is testing

Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 101
Testing effectiveness (Phase 2)Study completedNCT01332656
What this trial is testing

Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

Who this might be right for
Ovarian Cancer Recurrent
Sanofi 154
Testing effectiveness (Phase 2)UnknownNCT04566952
What this trial is testing

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian and Fallopian Tube Cysts and NeoplasmsNeoplasms by Site+16 more
Xiaoxiang Chen 68
Early research (Phase 1)Looking for participantsNCT05942300
What this trial is testing

CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Lan Coffman 30
Not applicableStudy completedNCT04573933
What this trial is testing

Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019.

Who this might be right for
Ovarian Neoplasm
University Hospital, Brest 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT05335993
What this trial is testing

A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.

Who this might be right for
Recurrent Ovarian CancerRecurrent Epithelial Cancer of OvaryRecurrent Epithelial Ovarian Cancer+4 more
CanariaBio Inc. 10
Testing effectiveness (Phase 2)Study completedNCT03657966
What this trial is testing

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
SOTIO a.s. 33
Testing effectiveness (Phase 2)Looking for participantsNCT05080556
What this trial is testing

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Who this might be right for
Ovarian CancerRelapsed Ovarian CancerFallopian Tube Cancer+4 more
University College, London 80
Testing effectiveness (Phase 2)Study completedNCT03783949
What this trial is testing

European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Universitaire Ziekenhuizen KU Leuven 122
Testing effectiveness (Phase 2)Study completedNCT02098343
What this trial is testing

P53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Who this might be right for
Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
Aprea Therapeutics 247
Early research (Phase 1)Study completedNCT01459380
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00090610
What this trial is testing

Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Duke University 150
Large-scale testing (Phase 3)Study completedNCT00043082
What this trial is testing

S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
SWOG Cancer Research Network 61
Large-scale testing (Phase 3)WithdrawnNCT02392676
What this trial is testing

Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations

Who this might be right for
Platinum Sensitive Relapsed Ovarian Cancer
AstraZeneca
Post-approval studies (Phase 4)Study completedNCT02476968
What this trial is testing

To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer

Who this might be right for
BRCA or HRR+ Mutated Ovarian Cancer Patients
AstraZeneca 181
Testing effectiveness (Phase 2)WithdrawnNCT01624493
What this trial is testing

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Hoosier Cancer Research Network
Testing effectiveness (Phase 2)Ended earlyNCT00910000
What this trial is testing

Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Dana-Farber Cancer Institute 15
Testing effectiveness (Phase 2)UnknownNCT04620954
What this trial is testing

Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin

Who this might be right for
Epithelial Ovarian Cancer
National Cancer Centre, Singapore 31
Large-scale testing (Phase 3)UnknownNCT04337632
What this trial is testing

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hunan Cancer Hospital 338
Next Page